SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-19-004934
Filing Date
2019-03-14
Accepted
2019-03-14 14:04:18
Documents
87
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10k.htm 10-K 1963499
2 EXHIBIT 23.1 ex23_1.htm EX-23.1 3058
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 15069
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 15069
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 7117
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 7033
13 image001.jpg GRAPHIC 99228
14 image002.jpg GRAPHIC 152171
  Complete submission text file 0001140361-19-004934.txt   7930694

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aqst-20181231.xml EX-101.INS 1094608
8 XBRL TAXONOMY EXTENSION SCHEMA aqst-20181231.xsd EX-101.SCH 64521
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqst-20181231_cal.xml EX-101.CAL 69613
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqst-20181231_def.xml EX-101.DEF 345153
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqst-20181231_lab.xml EX-101.LAB 903821
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqst-20181231_pre.xml EX-101.PRE 510625
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38599 | Film No.: 19680621
SIC: 2834 Pharmaceutical Preparations